| Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer (NCT00387764) | GlaxoSmithKline | 2006-09-01 |
| Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma (NCT00380354) | GlaxoSmithKline | 2006-09-01 |
| Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age (NCT00345579) | GlaxoSmithKline | 2006-09-01 |
| Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age (NCT00379977) | GlaxoSmithKline | 2006-09-01 |
| A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus (NCT00437164) | GlaxoSmithKline | 2006-09-01 |
| Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older Adults (NCT00380211) | GlaxoSmithKline | 2006-09-01 |
| FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old Subjects (NCT00370097) | GlaxoSmithKline | 2006-08-30 |
| Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma (NCT00406757) | GlaxoSmithKline | 2006-08-30 |
| P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic Pain (NCT00390845) | GlaxoSmithKline | 2006-08-30 |
| Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children (NCT00360230) | GlaxoSmithKline | 2006-08-30 |
| Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food (NCT00419692) | GlaxoSmithKline | 2006-08-24 |
| Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary Disease (NCT00376714) | GlaxoSmithKline | 2006-08-16 |
| A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors (NCT00743067) | GlaxoSmithKline | 2006-08-09 |
| Clinical Evaluation of BW430C in Epilepsy (NCT00395694) | GlaxoSmithKline | 2006-08-07 |
| Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine (NCT00344318) | GlaxoSmithKline | 2006-08-07 |
| A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis. (NCT00381394) | GlaxoSmithKline | 2006-08-04 |
| Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer (NCT00429299) | GlaxoSmithKline | 2006-08-01 |
| Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer (NCT00374322) | GlaxoSmithKline | 2006-08-01 |
| Study to Assess GW642444 in Asthma Patients (NCT00381667) | GlaxoSmithKline | 2006-08-01 |
| A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS) (NCT00394186) | GlaxoSmithKline | 2006-08-01 |
| A Study To Determine The Effect Of SB-480848 On Asthma (NCT00368576) | GlaxoSmithKline | 2006-08-01 |
| A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease) (NCT00392587) | GlaxoSmithKline | 2006-08-01 |
| Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes (NCT00376038) | GlaxoSmithKline | 2006-08-01 |
| A Methodology Study To Look At Genes In Lung Cells And Tissue From Asthmatic Patients (NCT00331292) | GlaxoSmithKline | 2006-08-01 |
| HLA-B*5701 And Hypersensitivity To Abacavir (NCT00373945) | GlaxoSmithKline | 2006-08-01 |
| Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors (NCT00471588) | GlaxoSmithKline | 2006-08-01 |
| Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines. (NCT00333450) | GlaxoSmithKline | 2006-08-01 |
| TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM) (NCT00451321) | GlaxoSmithKline | 2006-07-31 |
| Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women (NCT00344032) | GlaxoSmithKline | 2006-07-28 |
| A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes (NCT00401583) | GlaxoSmithKline | 2006-07-28 |
| Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years (NCT00346073) | GlaxoSmithKline | 2006-07-13 |
| Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease (NCT00348140) | GlaxoSmithKline | 2006-07-12 |
| Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease (NCT00348309) | GlaxoSmithKline | 2006-07-06 |
| Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097 (NCT00310388) | GlaxoSmithKline | 2006-07-05 |
| Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men (NCT00363311) | GlaxoSmithKline | 2006-07-01 |
| GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures (NCT00567424) | GlaxoSmithKline | 2006-07-01 |
| Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib (NCT00356564) | GlaxoSmithKline | 2006-07-01 |
| Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting (NCT00366834) | GlaxoSmithKline | 2006-07-01 |
| Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above (NCT00345904) | GlaxoSmithKline | 2006-07-01 |
| Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814 (NCT00403585) | GlaxoSmithKline | 2006-07-01 |
| Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer (NCT00347919) | GlaxoSmithKline | 2006-07-01 |
| Pharmacokinetic Study Of EPZICOM Tablet (NCT00337922) | GlaxoSmithKline | 2006-07-01 |
| Effects Of Atorvastatin On Macrophage Activity And Plaque Inflammation Using Magnetic Resonance Imaging (NCT00368589) | GlaxoSmithKline | 2006-07-01 |
| The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial (NCT00347360) | GlaxoSmithKline | 2006-07-01 |
| A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC) (NCT00726323) | GlaxoSmithKline | 2006-06-30 |
| Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease (NCT00381238) | GlaxoSmithKline | 2006-06-20 |
| A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's (NCT00331149) | GlaxoSmithKline | 2006-06-20 |
| Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan (NCT00356603) | GlaxoSmithKline | 2006-06-20 |
| HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Failing Fludarabine and Alemtuzumab (NCT00349349) | GlaxoSmithKline | 2006-06-01 |
| Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA (NCT00334607) | GlaxoSmithKline | 2006-06-01 |
| Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis) (NCT01376154) | GlaxoSmithKline | 2006-06-01 |
| Safety and Immune Response Study of an Investigational Pneumococcal Vaccine. (NCT00327522) | GlaxoSmithKline | 2006-06-01 |
| This Study Will Examine the Effects of GSK256066 to Protect Mild Steroid-naive Asthmatics Against an Antigen Challenge (NCT00445510) | GlaxoSmithKline | 2006-06-01 |
| Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine. (NCT00334334) | GlaxoSmithKline | 2006-06-01 |
| Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women (NCT00337818) | GlaxoSmithKline | 2006-06-01 |
| The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome (NCT00357097) | GlaxoSmithKline | 2006-06-01 |
| Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years. (NCT00326118) | GlaxoSmithKline | 2006-06-01 |
| Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria (NCT00344006) | GlaxoSmithKline | 2006-06-01 |
| Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib (NCT00335881) | GlaxoSmithKline | 2006-06-01 |
| Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib (NCT00332566) | GlaxoSmithKline | 2006-06-01 |
| Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide (NCT00358540) | GlaxoSmithKline | 2006-06-01 |
| First Study in Humans With GSK424887 (NCT01059591) | GlaxoSmithKline | 2006-05-25 |
| A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo Study (NCT00432679) | GlaxoSmithKline | 2006-05-24 |
| First Study in Humans With GSK206136 (NCT01059578) | GlaxoSmithKline | 2006-05-23 |
| Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients (NCT00347139) | GlaxoSmithKline | 2006-05-23 |
| A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia (NCT00379756) | GlaxoSmithKline | 2006-05-22 |
| Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data (NCT00363480) | GlaxoSmithKline | 2006-05-17 |
| Study to Evaluate an Influenza Vaccine Candidate (NCT00321373) | GlaxoSmithKline | 2006-05-11 |
| A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects (NCT00406432) | GlaxoSmithKline | 2006-05-09 |
| Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population (NCT00327665) | GlaxoSmithKline | 2006-05-01 |
| Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy (NCT00355082) | GlaxoSmithKline | 2006-05-01 |
| Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM) (NCT00387972) | GlaxoSmithKline | 2006-05-01 |
| Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q) (NCT00346775) | GlaxoSmithKline | 2006-05-01 |
| Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine (NCT00329576) | GlaxoSmithKline | 2006-05-01 |
| Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia (NCT00354809) | GlaxoSmithKline | 2006-05-01 |
| Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer (NCT00312013) | GlaxoSmithKline | 2006-05-01 |
| A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects (NCT00363142) | GlaxoSmithKline | 2006-05-01 |
| Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA) (NCT00329355) | GlaxoSmithKline | 2006-05-01 |
| SB-742457 And Donepezil In Alzheimer's Disease (NCT00348192) | GlaxoSmithKline | 2006-05-01 |
| Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial (NCT00310375) | GlaxoSmithKline | 2006-05-01 |
| Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC (NCT00322335) | GlaxoSmithKline | 2006-05-01 |
| Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan (NCT00330616) | GlaxoSmithKline | 2006-05-01 |
| Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast Cancer (NCT00356811) | GlaxoSmithKline | 2006-05-01 |
| A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine. (NCT00405119) | GlaxoSmithKline | 2006-05-01 |
| Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients (NCT00333021) | GlaxoSmithKline | 2006-05-01 |
| Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea (NCT00329459) | GlaxoSmithKline | 2006-05-01 |
| Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms (NCT00343486) | GlaxoSmithKline | 2006-05-01 |
| Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above (NCT00319098) | GlaxoSmithKline | 2006-05-01 |
| Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB) (NCT00388076) | GlaxoSmithKline | 2006-04-28 |
| Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate (NCT00321763) | GlaxoSmithKline | 2006-04-27 |
| Human Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine (NCT00316693) | GlaxoSmithKline | 2006-04-26 |
| Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects (NCT00317109) | GlaxoSmithKline | 2006-04-19 |
| Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment (NCT00359463) | GlaxoSmithKline | 2006-04-18 |
| Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese Children (NCT00307021) | GlaxoSmithKline | 2006-04-07 |
| GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast Cancer (NCT00371488) | GlaxoSmithKline | 2006-04-06 |
| A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults (NCT00239577) | GlaxoSmithKline | 2006-04-05 |
| Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males. (NCT00309166) | GlaxoSmithKline | 2006-04-05 |
| REQUIP RLS Post Marketing Surveillance (NCT01327339) | GlaxoSmithKline | 2006-04-01 |
| Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine (NCT00327184) | GlaxoSmithKline | 2006-04-01 |
| Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity (NCT00340080) | GlaxoSmithKline | 2006-04-01 |